| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 04/22/2010 | US20100099667 Bridged heterocyclic compounds and methods of use |
| 04/22/2010 | US20100099658 Di(arylamino)aryl compound |
| 04/22/2010 | US20100099106 Cell death inhibitor |
| 04/21/2010 | EP2176248A1 New antimicrobial compounds, their synthesis and their use for treatment of mammalian infections |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | CN101696977A Method for determining stage of neurofibrillary degeneration |
| 04/15/2010 | WO2010042925A2 Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 04/15/2010 | WO2010042030A1 Aspartyl protease inhibitors |
| 04/15/2010 | US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 04/15/2010 | US20100093707 Acid amide derivatives, process for their production and pesticides containing them |
| 04/08/2010 | WO2009053763A8 New non-peptide derivatives as bradykinin b1 antagonists |
| 04/08/2010 | US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2010 | US20100087320 Arylphenyl-substituted cyclic keto-enols |
| 04/06/2010 | US7691904 Diisopropylphenyl esters of N-amino- or N-heterocyclyl-alkanamic acids, e.g., N-(2-Piperidin-1-yl-ethyl)-succinamic acid 2,6-diisopropylphenyl ester; induction and maintenance of anesthesia or sedation as well as treating cancer, nervous system disorders and respiratory system disorders, |
| 04/06/2010 | US7691847 Method of treating neurological diseases and disorders |
| 04/01/2010 | WO2010034982A1 Ligands for aggregated tau molecules |
| 04/01/2010 | US20100081652 Cinnamoyl Compound and Use Thereof |
| 04/01/2010 | CA2737028A1 Ligands for aggregated tau molecules |
| 03/31/2010 | CN101687827A aminodihydrothiazine derivatives substituted with cyclic groups |
| 03/25/2010 | CA2770302A1 Small molecule compounds for stem cell differentiation |
| 03/23/2010 | US7683055 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 03/11/2010 | US20100063277 Intramolecular C-H amination with sulfonyl azides |
| 03/11/2010 | US20100063036 Substituted morpholine and thiomorpholine derivatives |
| 03/11/2010 | US20100063034 Conjugated psychotropic drugs and uses thereof |
| 03/11/2010 | US20100063033 administering (2,6-Dimethyl-4-morpholin-4-yl-phenyl)-carbamic acid butyl ester, for the treatment of bipolar disorders, seizure disorders, anxiety disorders, neuropathic pain and migraine pain disorders or neurodegenerative disorders |
| 03/10/2010 | CN101665472A Preparation method of 2-methyl-3. 4-dihydro-4-oxo-2H-1. 2-benzothiazine-3-carboxylic ethyl ester-1, 1-dioxide |
| 03/04/2010 | US20100056504 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester- introduced phenyl group as substituents |
| 03/04/2010 | US20100056503 Compounds for modulating integrin CD11b/CD18 |
| 03/02/2010 | US7671198 Process for preparing intermediates to 5-HT4 receptor agonist compounds |
| 02/24/2010 | EP2155705A2 Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria |
| 02/18/2010 | WO2010019911A2 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
| 02/18/2010 | CA2734305A1 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
| 02/11/2010 | US20100035869 Targeted nitroxide agents |
| 02/11/2010 | US20100035865 Sulfonamides and Pharmaceutical Compositions Thereof |
| 02/11/2010 | US20100034773 5,6-dihydro-1h-pyridin-2-one compounds |
| 02/10/2010 | EP2151435A1 Pharmaceutical composition for treatment of alzheimer's disease |
| 02/10/2010 | CN100588655C Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 02/09/2010 | US7659267 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 02/09/2010 | US7659266 N1-[(3S)-2-hydroxytetrahydrofuran-3-yl]-N2-[imino(10H-phenothiazin-2-yl)methyl]-L-leucinamide; (3S)-3-({N-[imino(10H-phenothiazin-2-yl)methyl]-L-leucyl}amino)tetrahydrofuran-2-yl acetate; hearing disorders, muscular dystrophy |
| 02/04/2010 | US20100029623 4-(1-amino-ethyl)-cyclohexylamine derivatives |
| 02/03/2010 | EP1250329B1 Phenothiazines in prill form |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655649 Inhibitors of Akt activity |
| 01/28/2010 | US20100022521 Compounds |
| 01/27/2010 | EP2147914A1 Aminodihydrothiazine derivatives substituted with cyclic groups |
| 01/26/2010 | US7652001 Lipophilic, potentiated ester derivatives of nucleoside/viricide derivatives; side effect reduction; viricides; antiproliferative agents; bone metabolism disorders; antimetobolic, -tumor agents and -carcinogenic agents; poxviruses; herpes viruses; influenza and hepatitis viruses |
| 01/21/2010 | US20100016550 Methods for Site-Specific Pegylation |
| 01/21/2010 | US20100016318 Anthranilamide inhibitors of aurora kinase |
| 01/21/2010 | US20100016295 Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity |
| 01/21/2010 | US20100016285 Heterocyclidene-n-(aryl) acetamide derivative |
| 01/21/2010 | US20100012931 Polycyclic compounds and organic electroluminescence device employing the same |
| 01/20/2010 | CN101631780A Phenothiazin derivatives for antiviral treatments |
| 01/19/2010 | US7648777 Blue electroluminescent compound and organic electroluminescent device using the same |
| 01/14/2010 | US20100009976 Benzothiazin-3-one compound and intermediate therefor |
| 01/13/2010 | EP2142505A1 Sulfonamides and pharmaceutical compositions thereof |
| 01/07/2010 | US20100004229 Potassium Channel Inhibitors |
| 12/31/2009 | US20090325944 Methods and Compositions for Modulating Glycosylation |
| 12/30/2009 | WO2009156535A1 Hydrazides of heterocyclic systems and use thereof in the treatment of neurodegenerative diseases |
| 12/30/2009 | EP2138487A1 Substituted morpholine and thiomorpholine derivatives for the treatment of bipolar disorders |
| 12/30/2009 | EP2137172A1 Phenothiazin derivatives for antiviral treatments |
| 12/29/2009 | US7638512 Phenylaminopropanol derivatives and methods of their use |
| 12/23/2009 | CN101611008A Modulators of C3A receptor and methods of use thereof |
| 12/23/2009 | CN100572555C Amplicon melting analysis with saturation dyes |
| 12/16/2009 | CN101602747A Preparation and application of 3, 7-disubstituted-N-hexyl phenothiazine derivative |
| 12/16/2009 | CN101602746A Preparation and application of 3-substituted-N-hexyl phenothiazine derivative |
| 12/16/2009 | CN100569754C Synthesis and application of serial ion liquid as candidate drug with anticancer activity |
| 12/15/2009 | US7632835 2-Cyclopentyl-N-(2-bromo-6-trifluoromethyl-4-(thio)morpholin-4-yl-phenyl)-acetamide; potent openers of the KCNQ family of potassium ion channels; antiepileptic agents; anticonvulsants; anxiolytic agents; neurodegenerative disorders; analgesics for headaches, neuropathic pain; bipolar disorders |
| 12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
| 12/10/2009 | US20090306370 Method Of Manufacturing An Organic Silicon Compound That Contains A Methacryloxy Group Or An Acryloxy Group |
| 12/10/2009 | US20090300855 Pyrido Thiazinium Dyes |
| 12/09/2009 | EP2130826A1 Annulins A, B, C or analogs as indoleamine 2,3-dioxygenase (IDO) inhibitors for treatment of cancer |
| 12/09/2009 | EP2130820A1 Antipruritics |
| 12/02/2009 | CN100564341C A method for inhibiting polymerization of (meth) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor |
| 12/01/2009 | US7626040 Substituted imidazole compounds as KSP inhibitors |
| 11/26/2009 | US20090291945 Cysteine protease inhibitors |
| 11/26/2009 | US20090291943 Process for preparing diaminophenothiazinium compounds |
| 11/24/2009 | US7622579 Hetero isonipecotic modulators of vanilloid VR1 receptor |
| 11/19/2009 | WO2009139213A1 Pharmaceutical composition for external application containing prochlorperazine |
| 11/19/2009 | WO2009137900A2 Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention |
| 11/19/2009 | CA2724007A1 Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention |
| 11/17/2009 | US7619246 Organic light emitting compound and organic light emitting device comprising the same |
| 11/17/2009 | US7619006 Conjugates with organic acids; uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents; the organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity |
| 11/11/2009 | EP2114410A2 N-amino tetrahydrothiazine derivatives, method of manufacture and use |
| 11/11/2009 | EP1742908B1 Non-nucleoside reverse transcriptase inhibitors |
| 11/11/2009 | EP1477186B1 Antipruritics |
| 11/11/2009 | CN100558365C Conjugated anti-psychotic drugs and uses thereof |
| 11/05/2009 | WO2009134617A1 Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease |
| 11/05/2009 | US20090275565 Substituted aralkyl derivatives |
| 11/05/2009 | CA2723207A1 Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease |
| 11/04/2009 | EP2113502A1 Hydrazyde type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 11/03/2009 | US7612067 Imidazopyridazine compounds |
| 11/03/2009 | CA2442423C Therapeutic drug for psychoneurotic disorders |
| 11/03/2009 | CA2360767C Tricyclic benzodiazepines as vasopressin receptor antagonists |
| 10/29/2009 | WO2009129726A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture |
| 10/29/2009 | US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics |
| 10/29/2009 | US20090270360 Dicarboxamide derivatives |
| 10/28/2009 | CN101565378A Preparation of derivative of dibenzoyl methane and application thereof |
| 10/27/2009 | CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 10/27/2009 | CA2376355C N-heterocyclic derivatives as nos inhibitors |
| 10/22/2009 | US20090264423 Serine-threonine protein kinase and parp modulators |